This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
This article was written by Follow Andrew Hecht is a 35-year Wall Street veteran covering commodities and precious metals. He runs the investing group...
“With electricity prices trending up and gas prices going down, most traditional gas-powered vehicles cost less to drive than their EV [electric vehicle] counterparts...
In late December, I recommended Vir Biotechnology, Inc. (NASDAQ:VIR) as a speculative Buy due to its long-term cash availability, experienced management team, collaborations with...